Scholars Central

Mini reviewPublished 27 Jun 2022

Biomaterial-based therapeutic strategies for obesity and its comorbidities

Authors: Akbar Nikkhah

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Obesity is a global public health problem that leads to many complications and comorbidities such as type 2 diabetes, cardiovascular disease and fatty liver. Drug therapy alone or in combination with lifestyle changes or surgery represent a major modality for combating obesity and its complications. However, most anti-obesity drugs are limited by bioavailability, target specificity, and potential toxic effects. Currently, only a handful of drugs, such as orlistat, liraglutide, and semaglutide, are approved for clinical treatment of obesity. Therefore, there is an urgent need for alternative treatment strategies [1]. Based on new knowledge of the etiology of obesity and efforts to integrate materials, chemistry, biotechnology, and pharmacies interdisciplinary, several new obesity treatment strategies are gradually entering the field of preclinical and clinical research.

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Research Journal of Basic and Clinical Studies.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Research Journal of Basic and Clinical Studies
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Akbar Nikkhah”